Virginia Retirement Systems
ACAD icon

Virginia Retirement Systems’s Acadia Pharmaceuticals ACAD Stock Holding History

Virginia Retirement Systems’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.65M Sell
81,698
-1,700
-2% -$45.6K 0.01% 588
2026
Q2 		$2.11M Buy
83,398
+2,400
+3% +$52.8K 0.01% 522
2026
Q1 		$1.8M Buy
80,998
+1,100
+1% +$26.3K 0.01% 455
2025
Q4 		$2.13M Buy
79,898
+18,050
+29% +$431K 0.01% 404
2025
Q3 		$1.32M Sell
61,848
-900
-1% -$21.3K 0.01% 515
2025
Q2 		$1.35M Sell
62,748
-8,700
-12% -$162K 0.01% 503
2025
Q1 		$1.19M Buy
+71,448
New +$1.3M 0.01% 521
2023
Q3 		$882K Sell
42,300
-15,100
-26% -$410K 0.01% 544
2023
Q2 		$1.37M Buy
57,400
+19,700
+52% +$438K 0.01% 457
2023
Q1 		$710K Buy
37,700
+8,300
+28% +$158K 0.01% 640
2022
Q4 		$468K Sell
29,400
-4,300
-13% -$67.2K ﹤0.01% 845
2022
Q3 		$551K Buy
+33,700
New +$546K 0.01% 781
2022
Q1 		$862K Sell
35,600
-2,000
-5% -$48.4K 0.01% 693
2021
Q4 		$878K Buy
37,600
+200
+0.5% +$4.02K 0.01% 703
2021
Q3 		$621K Buy
37,400
+6,700
+22% +$129K 0.01% 754
2021
Q2 		$749K Buy
30,700
+16,400
+115% +$370K 0.01% 740
2021
Q1 		$369K Buy
14,300
+1,700
+13% +$74.8K ﹤0.01% 951
2020
Q4 		$674K Sell
12,600
-15,100
-55% -$750K 0.01% 743
2020
Q3 		$1.14M Sell
27,700
-3,000
-10% -$130K 0.01% 511
2020
Q2 		$1.49M Buy
30,700
+3,300
+12% +$158K 0.02% 457
2020
Q1 		$1.16M Buy
27,400
+20,900
+322% +$861K 0.02% 495
2019
Q4 		$278K Buy
+6,500
New +$283K ﹤0.01% 1050

Other funds holding ACAD

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Yousif Capital Management
Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Virginia Retirement Systems's ACAD Position: Q3 2026 in Review

Virginia Retirement Systems reduced its Acadia Pharmaceuticals (ACAD) stake by 2% in Q3 2026, selling an estimated $45.6K and leaving 81,698 shares worth $1.65M. The position accounts for 0.01% of the portfolio, ranked #588.

Virginia Retirement Systems first reported a position in ACAD in Q4 2019 and has held it in 22 quarters since. The position peaked at $2.13M in Q4 2025. 71 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

  • Virginia Retirement Systems held 81,698 shares of Acadia Pharmaceuticals worth $1.65M as of Q3 2026.
  • Virginia Retirement Systems sold 1,700 Acadia Pharmaceuticals shares in Q3 2026, an estimated $45.6K.
  • Acadia Pharmaceuticals made up 0.01% of Virginia Retirement Systems's portfolio in Q3 2026, its #588 holding.
  • Virginia Retirement Systems first reported a position in Acadia Pharmaceuticals in Q4 2019 and has held it in 22 quarters since.
  • Virginia Retirement Systems's Acadia Pharmaceuticals position peaked at $2.13M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.